Oksitosin Terapisi Çocuklarda Yeme Davranışlarını İyileştirebilir Tek Akıl-1 Gen Mutasyonu

References (8)

1. Lawson EA. The effects of oxytocin on eating behaviour and metabolism in humans. Nat Rev Endocrinol. 2017
2. 13(12):700-709. [CrossRef] 2. Bonnefond A, Raimondo A, Stutzmann F, et al. Loss of function mutations in SIM1 contribute to obesity and Prader Willi like features. J Clin Invest. 2013
3. 123(7):3037-3041. [CrossRef] 3. Michaud JL, Boucher F, Melnyk A, et al. SIM1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum Mol Genet. 2001
4. 10(14): 1465-1473. [CrossRef] 4. MillerJL, Tamura R, Butler MG, et al. Oxytocin treatment in children with Prader-Willi syndrome: a double-blind, placebo-controlled, crossover study. Am J Med Genet A. 2017
5. 173(5):1243-1250. [CrossRef] 5. Kublaoui BM, Gemelli T, Tolson KP, Wang Y, Zinn AR. Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol Endocrinol. 2008
6. 22(7):1723-1734. [CrossRef] 6. McCormack SE, Blevins JE, Lawson EA. Metabolic effects of oxytocin. Endocr Rev. 2020
7. 41(2):121-145. [CrossRef] 7. Hsu EA, Miller JL, Perez FA, Roth CL. Oxytocin and naltrexone successfully treat hypothalamic obesity in a boy post-craniopharyngioma resection. J Clin Endocrinol Metab. 2018
8. 103(2):370-375. [CrossRef]